Evandro de Azambuja
Université Libre de Bruxelles(BE)Institut Jules Bordet(BE)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)(2022)2,509 cited
- → Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98(2013)1,636 cited
- → Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer(2021)1,582 cited
- → Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer(2017)1,370 cited
- → Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial(2012)1,303 cited
- → ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer